Robert W Baird Raises Charles River Laboratories International (NYSE:CRL) Price Target to $268 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target upped by JPMorgan Chase & Co. from $270.00 to $280.00 in a research note published on Thursday, Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Several other brokerages also recently issued reports on CRL. UBS Group decreased […]
Charles River Laboratories International (NYSE:CRL) Releases Quarterly Earnings Results, Beats Expectations By $0 07 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares rose 7.3% during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $237.16 and last traded at $236.41. Approximately 459,031 shares traded hands during mid-day trading, a decline of 17% from the average daily volume of […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target lifted by Evercore ISI from $260.00 to $265.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s target price would indicate a potential upside of 8.54% from […]